1.1 A bill for an act
1.2 relating to higher education; requiring a report; canceling an appropriation;
1.3 appropriating money for amyotrophic lateral sclerosis research; repealing Laws
1.4 2022, chapter 42, section 2, as amended.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6 Section 1. APPROPRIATION; ALS RESEARCH.
1.7 (a) Of the amount appropriated from the general fund to the commissioner of the Office
1.8of Higher Education pursuant to Laws 2022, chapter 42, section 2, paragraph (b), as amended
1.9by Laws 2024, chapter 124, article 1, section 1, and Laws 2024, chapter 127, article 34,
1.10section 1, $15,000,000 is canceled.
1.11 (b) $15,000,000 in fiscal year 2026 is appropriated from the general fund to the Board
1.12of Regents of the University of Minnesota for a collaborative partnership with the Mayo
1.13Clinic to engage in ongoing research into amyotrophic lateral sclerosis (ALS), with the goal
1.14of bettering the lives of individuals with ALS and finding a cure for the disease. This is a
1.15onetime appropriation. Notwithstanding Minnesota Statutes, section 16A.28, unencumbered
1.16balances under this section do not cancel until June 30, 2029.
1.17 (c) Beginning January 15, 2026, and annually thereafter until January 15, 2030, or until
1.18the funds are fully expended, whichever occurs first, the Board of Regents of the University
1.19of Minnesota must submit a report to the legislature specifying how funds appropriated
1.20under this section have been used by the collaborative partnership.
1Section 1.
25-05066 as introduced03/21/25 REVISOR VH/EH
SENATE
STATE OF MINNESOTA
S.F. No. 3155NINETY-FOURTH SESSION
(SENATE AUTHORS: HOFFMAN, Abeler, Dibble, Utke and Hawj)
OFFICIAL STATUSD-PGDATE
Introduction and first reading04/01/2025
Referred to Higher Education 2.1 Sec. 2. REPEALER.
2.2 Laws 2022, chapter 42, section 2, as amended by Laws 2024, chapter 124, article 1,
2.3section 1, Laws 2024, chapter 127, article 34, section 1, is repealed.
2Sec. 2.
25-05066 as introduced03/21/25 REVISOR VH/EH Laws 2022, chapter 42, section 2, as amended by Laws 2024, chapter 124, article 1, section 1; as
amended by Laws 2024, chapter 127, article 34, section 1
Section 1. Laws 2022, chapter 42, section 2, is amended to read:
Sec. 2. APPROPRIATION; ALS RESEARCH.
(a) $396,000 in fiscal year 2023 is appropriated from the general fund to the commissioner of
the Office of Higher Education to award competitive grants to applicants for research into
amyotrophic lateral sclerosis (ALS). The commissioner may work with the Minnesota Department
of Health to administer the grant program, including identifying clinical and translational research
and innovations, developing outcomes and objectives with the goal of bettering the lives of
individuals with ALS and finding a cure for the disease, and application review and grant recipient
selection. Not more than $396,000 may be used by the commissioner to administer the grant program.
This is a onetime appropriation. Notwithstanding Minnesota Statutes, section 16A.28, unencumbered
balances under this section do not cancel until June 30, 2026.
(b) $19,604,000 in fiscal year 2024 is appropriated from the general fund to the commissioner
of the Office of Higher Education to award competitive grants to applicants for research into
amyotrophic lateral sclerosis (ALS). The commissioner may work with the Minnesota Department
of Health to administer the grant program, including identifying clinical and translational research
and innovations, developing outcomes and objectives with the goal of bettering the lives of
individuals with ALS and finding a cure for the disease, and application review and grant recipient
selection. Up to $15,000,000 may be used by the commissioner for grants to the Amyotrophic
Lateral Sclerosis Association, Never Surrender, or other similar organizations to award and administer
competitive grants to applicants for research into ALS under this section. This is a onetime
appropriation. Notwithstanding Minnesota Statutes, section 16A.28, unencumbered balances under
this section do not cancel until June 30, 2029. Notwithstanding Minnesota Statutes, section 16B.98,
subdivision 14, the commissioner, the Amyotrophic Lateral Sclerosis Association, Never Surrender,
and other similar organizations may use up to a total of five percent of this appropriation for
administrative costs.
(c) Grants shall be awarded to support clinical and translational research related to ALS. Research
topics may include but are not limited to environmental factors, disease mechanisms, disease models,
biomarkers, drug development, clinical studies, precision medicine, medical devices, assistive
technology, and cognitive studies.
(d) Eligible applicants for the grants are research facilities, universities, and health systems
located in Minnesota. Applicants must submit proposals to the commissioner in the time, form, and
manner established by the commissioner. Applicants may coordinate research endeavors and submit
a joint application. When reviewing the proposals, the commissioner shall make an effort to avoid
approving a grant for an applicant whose research is duplicative of an existing grantee's research.
(e) Beginning January 15, 2023, and annually thereafter until January 15, 2030, the commissioner
shall submit a report to the legislature specifying the applicants receiving grants under this section,
the amount of each grant, the purposes for which the grant funds were used, and the amount of the
appropriation that is unexpended. The report must also include relevant findings, results, and
outcomes of the grant program, and any other information which the commissioner deems significant
or useful.
EFFECTIVE DATE.This section is effective the day following final enactment.
1R
APPENDIX
Repealed Minnesota Session Laws: 25-05066